APP and Alzheimer disease: To analyze the potential therapeutic effectiveness of LGF in AD, we have used Tg2576 transgenic mice (from now APPswe mice) that over-express the Swedish APP mutation (K670N/M671L) on a C57Bl/6 9 SJL background [18].